{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:58:14Z","timestamp":1792432694238,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-025-04276-4","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:43:20Z","timestamp":1763667800000},"page":"140-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CT Hepatic Arteriography for Improved Detection and Ablation of Occult HCC Nodules: A Retrospective Analysis"],"prefix":"10.1007","volume":"49","author":[{"given":"Riccardo","family":"Muglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"Dulcetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bertuletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Puijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Calazans","family":"Odisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4935-8110","authenticated-orcid":false,"given":"Paolo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"4276_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol"},{"issue":"1","key":"4276_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"key":"4276_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68:723\u201350. https:\/\/doi.org\/10.1002\/hep.29913.","journal-title":"Hepatology"},{"issue":"10","key":"4276_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.crad.2023.06.005","volume":"78","author":"HM Kwok","year":"2023","unstructured":"Kwok HM, Chau CM, Lee HCH, Wong T, Chan HF, Luk WH, et al. Gadoxetic acid in hepatocellular carcinoma and liver metastases: pearls and pitfalls. Clin Radiol. 2023;78(10):715\u201323. https:\/\/doi.org\/10.1016\/j.crad.2023.06.005.","journal-title":"Clin Radiol"},{"issue":"6","key":"4276_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/cancers16061193","volume":"16","author":"RS Puijk","year":"2024","unstructured":"Puijk RS, Dijkstra M, van der Lei S, Schulz HH, Vos DJW, Timmer FEF, et al. The added value of transcatheter CT hepatic angiography (CTHA) image guidance in percutaneous thermal liver ablation: an experts\u2019 opinion pictorial essay. Cancers (Basel). 2024;16(6):1193. https:\/\/doi.org\/10.3390\/cancers16061193.","journal-title":"Cancers (Basel)"},{"key":"4276_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00270-023-03545-4","volume":"46","author":"MLJ Smits","year":"2023","unstructured":"Smits MLJ, Bruijnen RCG, Tetteroo P, et al. Hepatic arteriography and C-arm CT-guided ablation (HepACAGA) to improve tumor visualization, navigation and margin confirmation in percutaneous liver tumor ablation. Cardiovasc Intervent Radiol. 2023;46:1365\u201374. https:\/\/doi.org\/10.1007\/s00270-023-03545-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4276_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00270-022-03333-6","volume":"46","author":"I Paolucci","year":"2023","unstructured":"Paolucci I, Lin Y-M, Jones AK, et al. Use of contrast media during CT-guided thermal ablation of colorectal liver metastasis for procedure planning is associated with improved immediate outcomes. Cardiovasc Intervent Radiol. 2023;46:327\u201336. https:\/\/doi.org\/10.1007\/s00270-022-03333-6.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4276_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00004728-198501000-00004","volume":"9","author":"O Matsui","year":"1985","unstructured":"Matsui O, Takashima T, Kadoya M, et al. Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas. J Comput Assist Tomogr. 1985;9:19\u201324. https:\/\/doi.org\/10.1097\/00004728-198501000-00004.","journal-title":"J Comput Assist Tomogr"},{"key":"4276_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1148\/radiol.2522081414","volume":"252","author":"A Kitao","year":"2009","unstructured":"Kitao A, Zen Y, Matsui O, et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography\u2013radiologic-pathologic correlation. Radiology. 2009;252:605\u201314. https:\/\/doi.org\/10.1148\/radiol.2522081414.","journal-title":"Radiology"},{"issue":"2","key":"4276_CR10","doi-asserted-by":"publisher","first-page":"e230099","DOI":"10.1148\/rycan.230099","volume":"6","author":"J Albuquerque","year":"2024","unstructured":"Albuquerque J, Lin Y-M, Paolucci I, O\u2019Connor CS, Tzeng C-W, Vauthey J-N, et al. Incidental ring-hyperenhancing liver micronodules at CT hepatic arteriography-guided percutaneous thermal ablation of colorectal liver metastases. Radiol: Imaging Cancer. 2024;6(2):e230099. https:\/\/doi.org\/10.1148\/rycan.230099.","journal-title":"Radiol: Imaging Cancer"},{"key":"4276_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289:816\u201330. https:\/\/doi.org\/10.1148\/radiol.2018181494.","journal-title":"Radiology"},{"key":"4276_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","volume":"40","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141\u20136. https:\/\/doi.org\/10.1007\/s00270-017-1703-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4276_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1148\/radiol.2021203715","volume":"301","author":"RS Puijk","year":"2021","unstructured":"Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301:533\u201340. https:\/\/doi.org\/10.1148\/radiol.2021203715.","journal-title":"Radiology"},{"key":"4276_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1148\/radiol.14131996","volume":"271","author":"MH Yu","year":"2014","unstructured":"Yu MH, Kim JH, Yoon J-H, et al. Small (\u22641-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology. 2014;271:748\u201360. https:\/\/doi.org\/10.1148\/radiol.14131996.","journal-title":"Radiology"},{"key":"4276_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7:308\u201319. https:\/\/doi.org\/10.1016\/j.gendis.2020.01.014.","journal-title":"Genes Dis"},{"key":"4276_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/JHC.S290197","volume":"8","author":"K Kim","year":"2021","unstructured":"Kim K, Kim TH, Kim TH, Seong J. Efficacy of local therapy for oligometastatic hepatocellular carcinoma: a propensity score matched analysis. J Hepatocell Carcinoma. 2021;8:35\u201344. https:\/\/doi.org\/10.2147\/JHC.S290197.","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"4276_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/cancers16030666","volume":"16","author":"E Kinsey","year":"2024","unstructured":"Kinsey E, Lee HM. Management of hepatocellular carcinoma in 2024: the multidisciplinary paradigm in an evolving treatment landscape. Cancers. 2024;16(3):666. https:\/\/doi.org\/10.3390\/cancers16030666.","journal-title":"Cancers"},{"issue":"2","key":"4276_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","volume":"26","author":"S van der Lei","year":"2025","unstructured":"van der Lei S, Puijk RS, Dijkstra M, Schulz HH, Vos DJW, De Vries JJJ, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol. 2025;26(2):187\u201399. https:\/\/doi.org\/10.1016\/S1470-2045(24)00660-0.","journal-title":"Lancet Oncol"},{"key":"4276_CR19","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1007\/s00261-018-1623-z","volume":"43","author":"RP Mathew","year":"2018","unstructured":"Mathew RP, Venkatesh SK. Liver vascular anatomy: a refresher. Abdom Radiol (NY). 2018;43:1886\u201395. https:\/\/doi.org\/10.1007\/s00261-018-1623-z.","journal-title":"Abdom Radiol (NY)"},{"key":"4276_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00276-020-02532-5","volume":"42","author":"AS Anwar","year":"2020","unstructured":"Anwar AS, Srikala J, Papalkar AS, et al. Study of anatomical variations of hepatic vasculature using multidetector computed tomography angiography. Surg Radiol Anat. 2020;42:1449\u201357. https:\/\/doi.org\/10.1007\/s00276-020-02532-5.","journal-title":"Surg Radiol Anat"},{"issue":"7","key":"4276_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","volume":"21","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Citterio D, Bhoori S, Bongini M, Miceli R, De Carlis L, et al. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial. Lancet Oncol. 2020;21(7):947\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(20)30224-2.","journal-title":"Lancet Oncol"},{"key":"4276_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.clinimag.2020.11.010","volume":"71","author":"Z Makovich","year":"2021","unstructured":"Makovich Z, Logemann J, Chen L, et al. Liver tumor ablation in difficult locations: microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2021;71:170\u20137. https:\/\/doi.org\/10.1016\/j.clinimag.2020.11.010.","journal-title":"Clin Imaging"},{"key":"4276_CR23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00270-018-2066-1","volume":"41","author":"CJ McCarthy","year":"2018","unstructured":"McCarthy CJ, Kilcoyne A, Li X, et al. Radiation dose and risk estimates of CT-guided percutaneous liver ablations and factors associated with dose reduction. Cardiovasc Intervent Radiol. 2018;41:1935\u201342. https:\/\/doi.org\/10.1007\/s00270-018-2066-1.","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-04276-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:56:36Z","timestamp":1767027396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-04276-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["4276"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-04276-4","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We must acknowledge that one of the co-authors, Prof. Martijn Meijerink, declares a conflict of interest, being part of the Editorial Board of CVIR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Informed consent for anonymous data publication was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}